A new study suggests that overstimulating key cancer-growth pathways, rather than shutting them down, could offer a novel way to target pancreatic tumors driven by KRAS mutations. New research points to a possible way to fight pancreatic cancer by turning the disease’s own growth signals against it. The research, published in the journal Aging, focused […]This is a curated summary.